Manumycin A inhibits triple-negative breast cancer growth through LC3-mediated cytoplasmic vacuolation death

Therapy resistance can be attributed to acquisition of anti-apoptotic mechanisms by the cancer cells. Therefore, developing approaches that trigger non-apoptotic cell death in cancer cells to compensate for apoptosis resistance will help to treat cancer effectively. Triple-negative breast cancers (T...

Descripción completa

Detalles Bibliográficos
Autores principales: Singha, P K, Pandeswara, S, Venkatachalam, M A, Saikumar, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563980/
https://www.ncbi.nlm.nih.gov/pubmed/23328664
http://dx.doi.org/10.1038/cddis.2012.192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563980/
https://www.ncbi.nlm.nih.gov/pubmed/23328664
http://dx.doi.org/10.1038/cddis.2012.192

Ejemplares similares